Anne-Marie Koop

6 245 15. Mihl C, Dassen WRM, Kuipers H. Cardiac remodelling: Concentric versus eccentric hypertrophy in strength and endurance athletes. Netherlands Hear J 2008;16:129–133. 16. Tabibiazar R, Wagner RA, Liao A, Quertermous T. Transcriptional Profiling of the Heart Reveals Chamber-Specific Gene Expression Patterns. Circ Res 2003;93:1193–1201. 17. Katz WE, Gasior TA, Quinlan JJ, Lazar JM, Firestone L, Griffith BP, Gorcsan J. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol Elsevier Masson SAS; 1996;27:384–391. 18. Schulman L, Leibowitz D, Anandarangam T, DiTullio M, McGregor C, Smith C, Homma S. Variability of right ventricular functional recovery after lung transplantation. Transplantation 1996;62:622–625. 19. Gorter TM, Verschuuren EAM, Veldhuisen DJ Van, Hoendermis ES, Erasmus ME, Bogaard HJ, Vonk Noordegraaf A, Berger RMF, Melle JP Van, Willems TP. Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension. Interact Cardiovasc Thorac Surg 2017;24:890–897. 20. Tuder RM, Archer SL, Dorfmuller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW. Relevant issues in the pathology and pathobiology of pulmonary hypertension. Turk Kardiyol Dern Ars Turkey; 2014;42 Supp l 1:5–16. 21. Ha M, KimVN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol Nature Publishing Group; 2014;15:509–524. 22. Espinoza-Lewis R, Wang D-Z. MicroRNAs in Heart Development. Curr Top Dev Biol 2016;100:279–317. 23. Divakaran V, Mann DL. The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure. Circ Res 2008;103:1072–1083. 24. Iacobazzi D, SuleimanM-S, GhorbelM, GeorgeS, CaputoM,TullohR. Cellularandmolecular basis of RV hypertrophy in congenital heart disease. Heart 2015;heartjnl-2015-308348. 25. Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol 2011;45:1239–1247. 26. Joshi SR, Dhagia V, Gairhe S, Edwards JG, McMurtry IF, Gupte SA. Microrna-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the sugen5416/hypoxia/ normoxia model of pulmonary arterial hypertension. Am J Physiol - Hear Circ Physiol S.A. Gupte, Department of Pharmacology, New York Medical College, Valhalla, United States; 2016;311:H689–H698. 27. Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay È, Nadeau V, Paradis R, Graydon C, Wong R, Johnson I, Paulin R, Lajoie AC, Perron J, Charbonneau E, Joubert P, Pibarot P, Michelakis ED, Provencher S, Bonnet S. Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation 2015;132:932–943. 28. Reddy S, Bernstein D. Molecular mechanisms of right ventricular failure. Circulation S. Reddy, Department of Pediatrics (Cardiology), Stanford Cardiovascular Institute, Stanford University, Lucile Packard Children’s Hospital, Palo Alto, United States; 2015;132:1734–1742.